Sendum

Traditional pharmaceutical supply chains are not designed to meet the demands of next-generation therapies. Sendum is pioneering innovative, mission-critical supply chain management solutions for patient-specific, time-critical medicines, including cell & gene therapies (CGT), mRNA, biologics, and other advanced therapies. With Sendum’s 3-Phase Resilience Plan, innovators de-risk their path to market by bringing their end-to-end therapy supply chains into controlled operation, from starting materials through manufacturing and patient delivery, helping ensure that life-saving products reach the right patient, at the right time, and under the right conditions.